FDA panel supports Enteromedics' Maestro weight loss device, despite concerns
This article was originally published in Clinica
Executive Summary
A US FDA advisory panel has voted in support of EnteroMedics’ Maestro weight loss device, despite its failure to meet its primary effectiveness endpoints in a pivotal study.